BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16311409)

  • 61. Recent advances in proteomics and its implications in pituitary endocrine disorders.
    Banerjee A; Goel A; Shah A; Srivastava S
    Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140700. PubMed ID: 34303023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetics of pituitary tumors: Focus on G-protein mutations.
    Lania A; Mantovani G; Spada A
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1004-17. PubMed ID: 14530508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular genetic advances in pituitary tumor development.
    Yates CJ; Lines KE; Thakker RV
    Expert Rev Endocrinol Metab; 2015 Jan; 10(1):35-53. PubMed ID: 30289047
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular Profile of a Pituitary Rhabdomyosarcoma Arising From a Pituitary Macroadenoma: A Case Report.
    Lu J; Chen L
    Front Endocrinol (Lausanne); 2021; 12():752361. PubMed ID: 34659131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New pituitary oncogenes.
    Heaney AP; Melmed S
    Endocr Relat Cancer; 2000 Mar; 7(1):3-15. PubMed ID: 10808192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Growth hormone-secreting pituitary adenoma in uniovular twin brothers: case report.
    Kurisaka M; Takei Y; Tsubokawa T; Moriyasu N
    Neurosurgery; 1981 Feb; 8(2):226-30. PubMed ID: 7193813
    [No Abstract]   [Full Text] [Related]  

  • 67. The use of mass spectrometry in a proteome-centered multiomics study of human pituitary adenomas.
    Li N; Desiderio DM; Zhan X
    Mass Spectrom Rev; 2022 Nov; 41(6):964-1013. PubMed ID: 34109661
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA microarrays: recent developments and applications to the study of pituitary tissues.
    Qian X; Scheithauer BW; Kovacs K; Lloyd RV
    Endocrine; 2005 Oct; 28(1):49-56. PubMed ID: 16311410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.
    Srirangam Nadhamuni V; Korbonits M
    Endocr Rev; 2020 Dec; 41(6):821-46. PubMed ID: 32201880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular markers in pituitary tumors.
    Robertson AM; Heaney AP
    Curr Opin Endocrinol Diabetes Obes; 2016 Aug; 23(4):324-30. PubMed ID: 27254269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Editorial: From genetic alterations to new molecular targets in pituitary disorders.
    Ferraris J; Perez-Millan MI; Petiti JP
    Front Endocrinol (Lausanne); 2024; 15():1375475. PubMed ID: 38384967
    [No Abstract]   [Full Text] [Related]  

  • 72. Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.
    Zhan X; Wang X; Cheng T
    Front Endocrinol (Lausanne); 2016; 7():54. PubMed ID: 27303365
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fshb-iCre mice are efficient and specific Cre deleters for the gonadotrope lineage.
    Wang H; Hastings R; Miller WL; Kumar TR
    Mol Cell Endocrinol; 2016 Jan; 419():124-38. PubMed ID: 26472536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathogenesis analysis of pituitary adenoma based on gene expression profiling.
    Wang W; Xu Z; Fu L; Liu W; Li X
    Oncol Lett; 2014 Dec; 8(6):2423-2430. PubMed ID: 25360166
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Aggressive pituitary adenomas--diagnosis and emerging treatments.
    Di Ieva A; Rotondo F; Syro LV; Cusimano MD; Kovacs K
    Nat Rev Endocrinol; 2014 Jul; 10(7):423-35. PubMed ID: 24821329
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pituitary tumors in patients with MEN1 syndrome.
    Syro LV; Scheithauer BW; Kovacs K; Toledo RA; LondoƱo FJ; Ortiz LD; Rotondo F; Horvath E; Uribe H
    Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):43-8. PubMed ID: 22584705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hand and foot abnormalities associated with genetic diseases.
    Mankin HJ; Jupiter J; Trahan CA
    Hand (N Y); 2011 Mar; 6(1):18-26. PubMed ID: 22379434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry.
    Liu Y; Wu J; Yan G; Hou R; Zhuang D; Chen L; Pang Q; Zhu J
    Proteome Sci; 2010 Jan; 8():2. PubMed ID: 20205839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
    Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
    Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetics, gene expression and bioinformatics of the pituitary gland.
    Davis SW; Potok MA; Brinkmeier ML; Carninci P; Lyons RH; MacDonald JW; Fleming MT; Mortensen AH; Egashira N; Ghosh D; Steel KP; Osamura RY; Hayashizaki Y; Camper SA
    Horm Res; 2009 Apr; 71 Suppl 2(Suppl 2):101-15. PubMed ID: 19407506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.